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S U M M A R Y
Objectives: The purpose of this study was to more clearly determine whether the clinical features and
outcomes of Staphylococcus aureus infections are different in elderly patients as compared with younger
adults.
Methods: Patients included in the database from our previous surveillance study on S. aureus infections
were stratiﬁed into two groups by age: those 65 years or older were considered ‘elderly’ and those aged
16 to 64 years were deﬁned as ‘younger’.
Results: Of 4334 patients with an S. aureus infection, 1546 (35.7%) were classiﬁed as elderly. Nosocomial
infections were more prevalent in the elderly group (55.2% vs. 42.8%, p < 0.001), while community-
associated infections were more common in the younger group (19.0% vs. 33.5%, p < 0.001). Elderly
patients were more likely to have underlying diseases and co-morbid conditions. Pneumonia was the
most common S. aureus infection in the elderly group and skin and soft tissue infection was the most
common in the younger group. The 30-day mortality rate among elderly patients wasmore than twice as
high as that in younger patients (22.7% vs. 8.7%, p < 0.001). Old age (65 years) was conﬁrmed to be a
strong independent risk factor for death in the entire study population (adjusted odds ratio 1.66; 95%
conﬁdence interval 1.32–2.08; p < 0.001), after adjustment for confounding variables.
Conclusions: Our study showed that the clinical features of elderly patients with S. aureus infection
differed substantially from those of younger patients in terms of underlying diseases, co-morbid
conditions, types of infection, and outcomes.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journa l homepage: www.e lsev ier .com/ locate / i j id1. Introduction
Staphylococcus aureus remains one of the most common
pathogens causing various infections, including skin and soft
tissue infections, bone and joint infections, pneumonia, and
bacteremia.1,2 Moreover, the mortality rate associated with
invasive staphylococcal infections is high despite antibiotic
therapy.1,3,4,5 Over the past three decades, the incidence of S.
aureus infections has increased andmethicillin resistance among S.
aureus isolates has been a growing problem.6,7With the continuing
increase in the annual incidence of S. aureus bacteremia across all
age groups and the continuing increase in the elderly population, S.* Corresponding author. Tel.: +82 2 3410 0320; fax: +82 2 3410 0328.
E-mail address: songjh@skku.edu (J.-H. Song).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.09.012aureus infections have become signiﬁcant causes of morbidity and
mortality in older patients.8,9,10
Older persons generally have greater susceptibility to infections
than younger adults.11 Urinary tract infections, pneumonia, skin
and soft tissue infections, intra-abdominal infections, infective
endocarditis, bacterial meningitis, tuberculosis, and herpes zoster
appear to have a special predilection for elderly individuals.11,12
Probably because of the increased prevalence of chronic diseases in
older individuals, bacteremic illnesses appear to be more frequent
and more often associated with death.12,13 Despite the clinical
signiﬁcance and increasing frequency of S. aureus bacteremia in
older adults, only few studies of S. aureus bacteremia in older
adults have been published.14 In addition, although it is well
established that many infections are both more frequent and more
often associated with mortality in older individuals, comprehen-
sive studies focusing on elderly patients with S. aureus infection,
not just bacteremia cases, are still limited.ses. Published by Elsevier Ltd. All rights reserved.
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whether the clinical features and outcomes of S. aureus infections
are different in elderly patients as compared with younger adults.
To address this question, we used the database from a prospective
surveillance study of S. aureus infections in Asian countries,
performed by the Asian Network for Surveillance of Resistant
Pathogens (ANSORP) study group.15,16
2. Methods
2.1. Study population
ANSORP performed a prospective surveillance study of S. aureus
infections from September 2004 to August 2006 in 30 centers
across nine Asian countries (Korea, China, Hong Kong, Taiwan,
Thailand, India, Sri Lanka, the Philippines, and Vietnam).15,16 A
post-hoc analysis of an observational cohort study was performed
to evaluate clinical features and outcomes of S. aureus infection in
relation to age. Only adult patients (16 years) were included in
this study in order to accurately reﬂect the difference between
elderly and younger adults.
2.2. Study design
Patients included in the database obtained from the surveil-
lance study for S. aureus infections were stratiﬁed into two
groups by age: those aged 65 years or older were considered
‘elderly’ and those aged 16 to 64 years were deﬁned as ‘younger’.
We compared data of the elderly group with those of the younger
group. All patients were also stratiﬁed by presumed site of
acquisition into community-onset infection or nosocomial
infection. A nosocomial infection was deﬁned as an infection
that occurred >72 h after admission to the hospital, and
infections diagnosed within the ﬁrst 72 h of hospitalization
were classiﬁed as community-onset infection, based on the time
the culture samples were obtained. Because many cases of S.
aureus infection that are present or incubating upon admission to
the hospital are nonetheless healthcare-associated, we refer to
non-nosocomial bacteremia as community-onset rather than
community-acquired. Community-onset infection was further
classiﬁed as community-associated and healthcare-associated,
as previously suggested.17
All patients were evaluated using a structured case record form.
The following information was collected from cases: baselineTable 1
Comparison of clinical characteristics in elderly versus younger patients with Staphylo
Clinical characteristics Overall (N=4334)
Elderly
(n=1546)
Younger
(n=2788)
p
Age (years), mean SD 758 4314 <0.001
Male 845 (54.7) 1681 (60.3) <0.001
Underlying disease
Pulmonary disease 361 (23.4) 220 (7.9) <0.001
Cardiovascular disease 457 (29.6) 310 (11.1) <0.001
Neurologic disease 480 (31.0) 284 (10.2) <0.001
Neoplastic disease 304 (19.7) 365 (13.1) <0.001
Liver disease 105 (6.8) 197 (7.1) 0.734
Renal disease 280 (18.1) 251 (9.0) <0.001
Diabetes mellitus 499 (32.3) 458 (16.4) <0.001
Acquisition, site of infection
Community-associated 293 (19.0) 934 (33.5)
Healthcare-associated 399 (25.8) 660 (23.7) <0.001
Nosocomial 854 (55.2) 1194 (42.8)
MRSA infection 1000 (64.7) 1438 (51.6) <0.001
Prior MRSA colonization or infection 119 (7.7) 168 (6.0) 0.034
SD, standard deviation; MRSA, methicillin-resistant Staphylococcus aureus.demographic information, underlying diseases (pulmonary dis-
ease, neoplastic disease, liver disease, heart disease, neurologic
disease, renal disease, and diabetes mellitus), co-morbid condi-
tions (intravenous drug use, prior acupuncture, alcoholism,
smoking, neutropenia, recent operation, implanted device, corti-
costeroid use, and immunosuppressive treatment), and the
presence of a central venous catheter, an indwelling urinary
catheter, nasogastric tube, or endotracheal tube. As this study was
observational, patient management and treatment regimens were
chosen by the patients’ physicians without any guidelines or
intervention from the study protocol or study investigators. The
main outcome measure used was the 30-day mortality rate.
2.3. Deﬁnitions
S. aureus infection was deﬁned by the isolation of S. aureus from
a normally sterile body site (e.g., blood, cerebrospinal ﬂuid, pleural
or peritoneal ﬂuid, aseptically obtained deep-tissue aspirates, or
surgical tissue samples). S. aureus pneumonia was diagnosed if
patients fulﬁlled the clinical and radiological criteria of pneumonia
and S. aureus was isolated from adequate lower respiratory
specimens.18 Primary bacteremia was deﬁned as unknown source
of bacteremia. Proven or possible catheter-related bloodstream
infection was also classiﬁed as primary bacteremia. The type of
infection was determined by physicians on the basis of the
isolation of S. aureus from the presumed portal of entry and clinical
evaluation according to the criteria proposed by the Centers for
Disease Control and Prevention.19 Neutropenia was deﬁned as an
absolute neutrophil count below 0.5  109/l.
2.4. Statistical analyses
The Student’s t-test was used to compare continuous variables
and the Chi-square or Fisher’s exact test to compare categorical
variables. To identify the independent risk factors for mortality, a
stepwise logistic regression analysis was performed to control for
the effects of confounding variables. All risk factors with an
association of p < 0.1 at the bivariate level were included in the
multivariate logistic model. Variables were selected using a
stepwise backward process by means of the likelihood ratio. Odds
ratios (OR) and their 95% conﬁdence intervals (CI) were calculated.
All p-values were two-tailed, and p < 0.05 was considered
statistically signiﬁcant. The PASW (version 17.0) software package
was used for statistical analyses.coccus aureus infection
Community-onset (n=2286) Nosocomial (n=2048)
Elderly
(n=692)
Younger
(n=1594)
p Elderly
(n=854)
Younger
(n=1194)
p
758 4114 <0.001 768 4613 <0.001
354 (51.2) 915 (57.4) 0.006 491 (57.5) 766 (64.2) 0.002
131 (18.9) 72 (4.5) <0.001 230 (26.9) 148 (12.4) <0.001
140 (20.2) 97 (6.1) <0.001 317 (37.1) 213 (17.8) <0.001
173 (25) 92 (5.8) <0.001 307 (35.9) 192 (16.1) <0.001
102 (14.7) 130 (8.2) <0.001 202 (23.7) 235 (19.7) 0.031
28 (4.0) 78 (4.9) 0.376 77 (9.0) 119 (10.0) 0.471
126 (18.2) 140 (8.8) <0.001 154 (18.0) 111 (9.3) <0.001
210 (30.3) 222 (13.9) <0.001 289 (33.8) 236 (19.8) <0.001
NA NA NA NA
334 (48.3) 551 (34.6) <0.001 666 (78.0) 887 (74.3) 0.054
34 (4.9) 49 (3.1) 0.031 85 (10.0) 119 (10.0) 0.992
Table 2
Comparison of co-morbid conditions in elderly versus younger patients with Staphylococcus aureus infection
Co-morbid condition Overall (N=4334) Community-onset (n=2286) Nosocomial (n=2048)
Elderly
(n=1546)
Younger
(n=2788)
p Elderly
(n=692)
Younger
(n=1594)
p Elderly
(n=854)
Younger
(n=1194)
p
IV drug user 5 (0.3) 66 (2.4) <0.001 3 (0.4) 61 (3.8) <0.001 2 (0.2) 5 (0.4) 0.480
History of acupuncture 12 (0.8) 5 (0.2) 0.004 8 (1.2) 2 (0.1) 0.001 4 (0.5) 3 (0.3) 0.406
Heavy alcoholic 80 (5.2) 161 (5.8) 0.409 29 (4.2) 65 (4.1) 0.901 51 (6.0) 96 (8.0) 0.074
Smoking 276 (17.9) 344 (12.3) <0.001 102 (14.7) 149 (9.3) <0.001 174 (20.4) 195 (16.3) 0.019
Neutropenia 14 (0.9) 44 (1.6) 0.065 4 (0.6) 13 (0.8) 0.544 10 (1.2) 31 (2.6) 0.023
Recent operation 188 (12.2) 237 (8.5) <0.001 40 (5.8) 65 (4.1) 0.074 148 (17.3) 172 (14.4) 0.072
Implanted device 120 (7.8) 139 (5.0) <0.001 49 (7.1) 53 (3.3) <0.001 71 (8.3) 86 (7.2) 0.351
Corticosteroid use 122 (7.9) 192 (6.9) 0.222 39 (5.6) 45 (2.8) 0.001 83 (9.7) 147 (12.3) 0.067
Immunosuppressant use 42 (2.7) 135 (4.8) 0.001 11 (1.6) 44 (2.8) 0.093 31 (3.6) 91 (7.6) <0.001
Central venous catheter 345 (22.3) 346 (12.4) <0.001 61 (8.8) 71 (4.5) <0.001 284 (33.3) 275 (23.0) <0.001
Endotracheal tube 271 (17.5) 228 (8.2) <0.001 61 (8.8) 45 (2.8) <0.001 210 (24.6) 183 (15.3) <0.001
Indwelling urinary catheter 522 (33.8) 429 (15.4) <0.001 103 (14.9) 85 (5.3) <0.001 419 (49.1) 344 (28.8) <0.001
Nasogastric tube 478 (30.9) 351 (12.6) <0.001 96 (13.9) 72 (4.5) <0.001 382 (44.7) 279 (23.4) <0.001
Prior hospitalization within 1 year 870 (56.3) 1141 (40.9) <0.001 334 (48.3) 548 (34.4) <0.001 536 (62.8) 593 (49.7) <0.001
IV, intravenous.
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3.1. Patient population
A total of 4334 patients with S. aureus infection were included in
the study. Of these, 1546 patients (35.7%)whose agewas 65 years or
older were classiﬁed as the elderly group, and the remaining 2788
patients constituted the younger group. The proportion of female
patients was higher (45.3% vs. 39.7%, p < 0.001), and more
methicillin-resistant S. aureus (MRSA) cases occurred (64.7% vs.
51.6%, p< 0.001) among elderly patients. Nosocomial infections
were more prevalent in the elderly group (55.2% vs. 42.8%,
p < 0.001), while community-associated infections were more
common in the younger group (19.0% vs. 33.5%, p < 0.001) (Table 1).
3.2. Underlying diseases and co-morbid conditions
The most common underlying diseases in the elderly group
were diabetes mellitus (DM) and neurologic disease (32.3% and
31.0%, respectively). In the elderly groupwith nosocomial infection,
the most common underlying disease was cardiovascular disease
(37.1%), followed by neurologic disease and DM (35.9% and 33.8%).
Elderlypatientsweremore likely tohaveacardiopulmonarydisease,
neurologic disease, neoplastic disease, renal disease, or diabetesTable 3
Comparison of clinical characteristics and co-morbid conditions in elderly versus young
Community-associated infection (n=122
Elderly (n=293) Younger (n=934
Underlying disease
Pulmonary disease 31 (10.6) 29 (3.1)
Cardiovascular disease 39 (13.3) 39 (4.2)
Neurologic disease 50 (17.1) 33 (3.5)
Neoplastic disease 18 (6.1) 35 (3.7)
Liver disease 9 (3.1) 29 (3.1)
Renal disease 19 (6.5) 21 (2.2)
Diabetes mellitus 62 (21.2) 99 (10.6)
Co-morbid condition
Heavy alcoholic 11 (3.8) 30 (3.2)
Smoking 20 (6.8) 67 (7.2)
Implanted device 4 (1.4) 9 (1.0)
Corticosteroid use 7 (2.4) 15 (1.6)
Immunosuppressant use 1 (0.3) 8 (0.9)
Indwelling urinary catheter 24 (8.2) 28 (3.0)
Nasogastric tube 29 (9.9) 33 (3.5)
Prior hospitalization within 1 year 1 (0.3) 10 (1.1)
MRSA infection 92 (31.4) 216 (23.1)
MRSA, methicillin-resistant Staphylococcus aureus.mellitus (all p< 0.05) (Table 1). However, the proportion of liver
disease in the elderly groupwas not signiﬁcantly different from that
in the younger group (6.8% vs. 7.1%, p = 0.734).
Elderly patients were more likely to have co-morbid conditions
such as smoking, recent operation, implanted device, insertion of
central venous catheter or nasogastric tube, indwelling urinary
catheter, or prior hospitalization, whereas intravenous drug users
were almost exclusively in the younger group (all p < 0.05) (Table
2). Neutropenia and immunosuppressant use were more common
in the younger group, especially in nosocomial infections.
Community-onset infection was further classiﬁed as commu-
nity-associated and healthcare-associated, and the comparison of
clinical characteristics and co-morbid conditions in elderly versus
younger patients among patients with community-onset S. aureus
infection are described in Table 3.
3.3. Type of infection
Pneumonia was the most common S. aureus infection in the
elderly group and skin and soft tissue infection was the most
common in the younger group. Among 478 elderly patients with S.
aureus pneumonia, 302 (63.2%) had hospital-acquired pneumonia,
of whom 111 (36.8%) had ventilator-associated pneumonia.
Bacteremia, pneumonia, and urinary tract infection were moreer patients, among patients with community-onset Staphylococcus aureus infection
7) Healthcare-associated infection (n=1059)
) p Elderly (n=399) Younger (n=660) p
<0.001 100 (25.1) 43 (6.5) <0.001
<0.001 101 (25.3) 58 (8.8) <0.001
<0.001 123 (30.8) 59 (8.9) <0.001
0.078 84 (21.1) 95 (14.4) 0.005
0.977 19 (4.8) 49 (7.4) 0.087
<0.001 107 (26.8) 119 (18.0) 0.001
<0.001 148 (37.1) 123 (18.6) <0.001
0.652 18 (4.5) 35 (5.3) 0.567
0.840 82 (20.6) 82 (12.4) <0.001
0.558 45 (11.3) 44 (6.7) 0.009
0.378 32 (8.0) 30 (4.5) 0.020
0.367 10 (2.5) 36 (5.5) 0.023
<0.001 79 (19.8) 57 (8.6) <0.001
<0.001 67 (16.8) 39 (5.9) <0.001
0.248 333 (83.5) 538 (81.5) 0.423
0.004 242 (60.7) 335 (50.8) 0.002
Table 4
Comparison of type of infection in elderly versus younger patients with
Staphylococcus aureus infection
Elderly
(n=1546)
Younger
(n=2788)
p
Primary bacteremia 192 (12.4) 244 (8.8) <0.001
Skin and soft tissue infection 327 (21.2) 1147 (41.1) <0.001
Bone and joint infection 48 (3.1) 114 (4.1) 0.102
Surgical site infection 28 (1.8) 162 (5.8) <0.001
Endocarditis 10 (0.6) 23 (0.8) 0.518
Pneumonia 478 (30.9) 331 (11.9) <0.001
Urinary tract infection 58 (3.8) 61 (2.2) 0.003
Concomitant bacteremia 325 (21.0) 438 (15.7) <0.001
Table 6
Comparison of underlying diseases and co-morbid conditions in elderly versus
younger patients with Staphylococcus aureus bacteremia
Elderly
(n=325)
Younger
(n=438)
p
Underlying disease
Pulmonary disease 59 (18.2) 37 (8.4) <0.001
Cardiovascular disease 98 (30.2) 71 (16.2) <0.001
Neurologic disease 114 (35.1) 44 (10.0) <0.001
Neoplastic disease 67 (20.6) 76 (17.4) 0.253
Liver disease 32 (9.8) 62 (14.2) 0.073
Renal disease 94 (28.9) 86 (19.6) 0.003
Diabetes mellitus 114 (35.1) 93 (21.2) <0.001
Co-morbid condition
IV drug user 1 (0.3) 37 (8.4) <0.001
History of acupuncture 3 (0.9) 3 (0.7) 0.713
Heavy alcoholics 18 (5.5) 36 (8.2) 0.153
Smoking 77 (23.7) 78 (17.8) 0.046
Neutropenia 3 (0.9) 16 (3.7) 0.017
Recent operation 36 (11.1) 31 (7.1) 0.054
Implanted device 46 (14.2) 28 (6.4) <0.001
Central venous catheter 121 (37.2) 115 (26.3) 0.001
Endotracheal tube 44 (13.5) 35 (8.0) 0.013
Indwelling urinary catheter 122 (37.5) 65 (14.8) <0.001
Nasogastric tube 108 (33.2) 56 (12.8) <0.001
Prior hospitalization within 1 year 192 (59.1) 210 (47.9) 0.002
IV, intravenous.
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and surgical site infection were more frequent in the younger
group (all p < 0.05) (Table 4).
3.4. Outcome and risk factors for mortality
The 30-day mortality rate among elderly patients was more
than twice as high as that in younger patients (22.7% (285/1255)
vs. 8.7% (213/2453), p < 0.001). This difference did not change
among patient subgroups, except in patients with S. aureus
pneumonia (Table 5). Even though no signiﬁcant difference was
found in the mortality rates of both groups with pneumonia, the
mortality rates were high in both groups (30.7% vs. 28.8%,
p = 0.593). The mortality in MRSA infections was signiﬁcantly
higher than in methicillin-sensitive S. aureus (MSSA) infections
(16.2% (326/2007) vs. 10.1% (172/1701), p < 0.001). In the
subgroup analysis including elderly patients or younger patients,
MRSA infections also showed a higher mortality than MSSA
infections in both groups (24.8% (194/781) vs. 19.2% (91/474),
p = 0.021; 10.8% (132/1226) vs. 6.6% (81/1227), p < 0.001).
Multivariate analysis was performed to identify independent
predictors of 30-day mortality. Old age (65 years) was conﬁrmed
to be a strong independent risk factor for death in the entire study
population (adjusted OR 1.66, 95% CI 1.32–2.08; p < 0.001), after
adjustment for confounding variables. Moreover, increasing age
(per 10 year-increment) was also signiﬁcantly associated with
mortality (adjusted OR 1.19, 95% CI 1.12–1.27; p < 0.001). Other
independent factors associated with mortality were solid tumor
(OR 3.09, 95% CI 2.36–4.03), neutropenia (OR 3.28, 95% CI 1.64–
6.53), intubated state (OR 3.75, 95% CI 2.74–5.14), concomitant
bacteremia (OR 3.14, 95% CI 2.45–4.03), nursing home residence
(OR 2.26, 95% CI 1.53–3.34), renal disease (OR 2.24, 95% CI 1.69–
2.96), pneumonia (OR 2.47, 95% CI 1.91–3.19), liver disease (ORTable 5
Comparison of 30-day mortality rates in elderly versus younger patients with
Staphylococcus aureus infection according to underlying conditions
Elderly Younger p
Overall 22.7% (285/1255) 8.7% (213/2453) <0.001
Acquisition site
Community-onset 15.2% (95/625) 5.1% (75/1484) <0.001
Nosocomial 30.2% (190/630) 14.2% (138/969) <0.001
Type of infection
Skin and soft tissue
infection
6.5% (21/325) 1.6% (18/1114) <0.001
Bone and joint infection 17.1% (7/41) 2.9% (3/105) 0.002
Surgical site infection 4% (1/25) 1.3% (2/158) 0.317
Pneumonia 30.7% (130/423) 28.8% (79/274) 0.593
Primary bacteremia 38.0% (70/184) 17.4% (39/224) <0.001
Concomitant bacteremia 36.0% (112/311) 18.9% (77/407) <0.001
Pathogen
MSSA 19.2% (91/474) 6.6% (81/1227) <0.001
MRSA 24.8% (194/781) 10.8% (132/1226) <0.001
MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant
Staphylococcus aureus.2.00, 95% CI 1.41–2.84), indwelling urinary catheter (OR 1.78, 95%
CI 1.34–2.36), and nosocomial acquisition (OR 1.42, 95% CI 1.12–
1.81). MRSA infection was not found to be independent risk factor
formortality after adjusting for other variables. Data on risk factors
for mortality and clinical impact of MRSA on outcome were
extensively described in our previous study.16
3.5. Subgroup analyses of bacteremia cases
To corroborate the evidence obtained regarding the clinical
features and outcome of S. aureus infection in elderly patients, we
further performed a subgroup analysis including patients with S.
aureus bacteremia (n = 763). In this subgroup analysis, all major
differences observed between elderly and younger patients with
regard to underlying diseases and co-morbid conditions persisted
(Table 6). The 30-day mortality in the elderly group was
signiﬁcantly higher than in the younger group (36.0% vs. 18.9%,
p < 0.001). In the multivariate analysis including patients with S.
aureus bacteremia, old age (65 years) was conﬁrmed to be a
strong independent risk factor for mortality (adjusted OR 2.15, 95%
CI 1.49–3.09; p < 0.001), after adjustment for confounding
variables. Similarly, increasing age (per 10 year-increment) was
also signiﬁcantly associated with mortality (adjusted OR 1.25, 95%
CI 1.13–1.39; p < 0.001).
4. Discussion
In the current study, we have analyzed data from a large,
prospective,multicenter cohort of patients with S. aureus infection,
evaluating the impact of advanced patient age on clinical features
and outcome. This study has provided a comprehensive evaluation
of the clinical characteristics of elderly patients with S. aureus
infection, as well as thosewith S. aureus bacteremia. It appears that
elderly patients with S. aureus infection indeed have distinctive
features when compared with younger adults, and that elderly
patients have higher overall mortality than younger patients.
The presence of co-morbid conditions in elderly populations
has been identiﬁed as a better predictor of impaired immunity
than chronological age.20,21 Not surprisingly, statistically signiﬁ-
cant differences between the elderly and younger populationswith
regard to the clinical characteristics of patients with S. aureus
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for co-morbid conditions, our data showed that old age was one of
the independent factors associated with increased mortality in
patients with S. aureus infection. Similar ﬁndings were also
conﬁrmed in the subgroup analysis including patients with S.
aureus bacteremia. McClelland et al. have also shown that elderly
patients have a greater risk of death with S. aureus bacteremia;22
they suggested that reasons for the higher mortality in elderly
patients might include a high prevalence of MRSA and no fever
prior to diagnosis. The adjusted OR (2.15; 95% CI 1.49–3.09) for
mortality in S. aureus bacteremia in the elderly group in our study
was comparable to that reported in the McClelland study (2.21;
95% CI 1.32–3.70).22
Notably, bacteremia and pneumonia, which are considered the
types of infection with a poor outcome, were more common in the
elderly group than in the younger group. Non-eradicable foci of
infection, such as lung and primary bacteremia, are associatedwith
higher mortality in S. aureus bacteremia.4 The higher proportion of
bacteremia and pneumonia in the elderly group could have
inﬂuenced the mortality rate, because these infections have been
found to be independent predictors of mortality in S. aureus
infection.4,5
Although the major focus in infectious diseases has been on
young adults with infection or immunocompromised hosts, the
vast majority of serious infectious diseases will be seen in the
elderly population.11 Therefore, clinicians who care for adult
patients should become familiar with the clinical problems in the
elderly population. We believe that providing data and informa-
tion on some of the unique aspects of aging and S. aureus infection
in this study will improve the care of this most cherished
population – the elderly.
Our study has several limitations. First, we did not use a co-
morbidity scoring system to assess baseline health status. Thus,
hidden bias that exists but was not adjusted for in our cohort may
overestimate the true relationship between aging and mortality,
even thoughwe performedmultivariate logistic analysis to control
for other confounding factors. The presence of co-morbid
conditions or severity of underlying illness is clearly a determinant
of the mortality in patients with bacterial infections. Second, we
were unable to obtain detailed information regarding the
appropriateness of antimicrobial therapy for many cases. Conse-
quently, we were unable to fully assess whether inappropriate
antimicrobial therapy, which might be one of the risk factors for
mortality, was more frequent in the elderly group. In addition, we
did not study the effect of different available options for S. aureus
infection on mortality. Third, we may have incorrectly identiﬁed
the type of infection or have failed to identify metastatic infections
in several cases, despite the prospective design of this study.
However, these limitations would likely affect elderly and younger
patients equally. Fourth, in our study a catheter-related blood-
stream infection was classiﬁed as primary bacteremia, since the
differentiation of catheter-related bloodstream infections from
primary bacteremia is frequently difﬁcult in clinical practice.
However, there is a clear difference in management and outcomes
for bacteremia with and without a removable focus. Finally, our
study was performed mainly in large institutions located in urban
areas and thus the results may or may not be applicable to small
community hospitals.
In conclusion, our study showed that elderly patients currently
account for a major proportion of adult patients with S. aureus
infection. DM and neurologic diseases were major predisposing
conditions and the clinical features of elderly patients with S.
aureus infection differed substantially from those of younger
patients in terms of underlying diseases, co-morbid conditions,
and type of infection. We also conﬁrmed that S. aureus infection in
the elderly population is a serious clinical condition, in which themortality rate is more than twice that in younger patients. Given
the increase in the elderly population and in the incidence of S.
aureus infection among elderly persons, further efforts should be
made to optimize the approach to, management of, and prevention
of S. aureus infections in this population.
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